Immucell (ICCC) Non-Current Assets (2010 - 2026)
Immucell (ICCC) posted Non-Current Assets of $25.55 million for Q2 2026, up 0.6% from $25.4 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Immucell's Non-Current Assets came in at $25.59 million, down 14.9% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
- In prior years, Immucell's Non-Current Assets was $30.06 million in FY2024 (-7.1%), $32.34 million in FY2023 (+4.8%), $30.87 million in FY2022 (+9.5%) and $28.2 million in FY2021 (unchanged).
- Quarterly Non-Current Assets has run from a low of $25.4 million in Q2 2025 to a high of $33.06 million in Q2 2023 over five years.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last seven quarters, with an average decline of 8.2%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2023, with growth of 15.4%; the weakest was Q2 2025, with a decline of 18.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 25.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.55 Mn |
| Dec 31, 2025 | 25.59 Mn |
| Sep 30, 2025 | 28.90 Mn |
| Jun 30, 2025 | 25.40 Mn |
| Mar 31, 2025 | 29.70 Mn |
| Dec 31, 2024 | 30.06 Mn |
| Sep 30, 2024 | 30.56 Mn |
| Jun 30, 2024 | 31.06 Mn |
| Mar 31, 2024 | 31.70 Mn |
| Dec 31, 2023 | 32.34 Mn |
| Sep 30, 2023 | 32.58 Mn |
| Jun 30, 2023 | 33.06 Mn |
| Mar 31, 2023 | 30.87 Mn |
| Dec 31, 2022 | 30.87 Mn |
| Sep 30, 2022 | 29.97 Mn |
| Jun 30, 2022 | 28.66 Mn |
| Mar 31, 2022 | 28.40 Mn |
| Dec 31, 2021 | 28.20 Mn |
| Sep 30, 2021 | 28.16 Mn |
| Jun 30, 2021 | 28.20 Mn |
API Access
Immucell Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();